Guggenheim analyst Howard Ma initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces Price Target of $29.
Enzo Biochem Announces Departure Of Hamid Erfanian And Appointment Of Kara Cannon As Interim CEO, Effective September 5, 2023
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023,
